Caricamento...
Clinical drug development for dementia with Lewy bodies: past and present
INTRODUCTION: Dementia with Lewy bodies (DLB) is an under-researched area despite being the second most common type of degenerative dementia after Alzheimer’s disease. It is an area of unmet need with no approved symptomatic or disease-modifying therapies. The pharmacological management of DLB is co...
Salvato in:
| Pubblicato in: | Expert Opin Investig Drugs |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6823159/ https://ncbi.nlm.nih.gov/pubmed/31614096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543784.2019.1681398 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|